Amneal Pharmaceuticals reported revenue of $796.20M and net income of $69.61M for the quarter ended Jun 2026, up 9.9% year over year. This income statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | 528.59M | 536.90M | 497.63M | 559.36M | 545.56M | 609.76M | 557.54M | 599.05M | 620.04M | 616.98M | 659.19M | 701.78M | 702.47M | 730.52M | 695.42M | 724.51M | 784.51M | 814.32M | 722.52M | 796.20M | |||||||||||||||||
| Cost of RevenueCost of Rev | 329.39M | 371.18M | 323.06M | 358.84M | 351.33M | 394.37M | 379.35M | 379.02M | 387.51M | 427.15M | 421.13M | 451.83M | 432.91M | 467.64M | 439.53M | 438.25M | 510.54M | 517.13M | 402.41M | 461.69M | |||||||||||||||||
| Gross Profit | 198.51M | 166.40M | 174.57M | 200.52M | 194.23M | 215.39M | 178.19M | 220.02M | 232.53M | 189.83M | 238.06M | 249.95M | 269.56M | 262.87M | 255.89M | 286.25M | 273.97M | 297.19M | 320.11M | 334.51M | |||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 48.93M | 51.87M | 52.80M | 50.75M | 50.23M | 41.91M | 38.69M | 37.80M | 41.38M | 46.09M | 39.30M | 36.05M | 61.10M | 54.27M | 40.04M | 47.96M | 63.35M | 34.82M | 38.38M | 39.02M | |||||||||||||||||
| Selling, General & AdministrativeSG&A | 91.40M | 97.22M | 98.67M | 98.81M | 100.07M | 102.16M | 102.10M | 105.57M | 113.01M | 109.00M | 112.59M | 116.46M | 118.69M | 128.69M | 118.29M | 124.27M | 137.81M | 146.46M | 138.86M | 148.72M | |||||||||||||||||
| Restructuring CostsRestructuring | 0.42M | 7.31M | 0.73M | 0.58M | 0.11M | 0.51M | 0.08M | 1.04M | 0.11M | 1.47M | 0.22M | 0.17M | 0.49M | 0.57M | 1.02M | 0.14M | 2.47M | 5.15M | 7.60M | ||||||||||||||||||
| Other Operating ExpensesOther Opex | -19.00M | -6.00M | 2.33M | -251.90M | 1.43M | -20.09M | -2.46M | 6.36M | -3.12M | 14.50M | -94.36M | -0.70M | 1.03M | -1.79M | 5.12M | 0.39M | 0.12M | 0.00M | 6.94M | -8.10M | |||||||||||||||||
| Operating ExpensesOpex | 140.75M | 156.41M | 152.19M | 149.55M | 150.89M | 144.17M | 141.30M | 143.45M | 155.42M | 155.20M | 153.36M | 152.74M | 179.96M | 183.44M | 158.90M | 173.25M | 201.31M | 183.75M | 182.40M | 195.34M | |||||||||||||||||
| Operating IncomeOp. Inc | 28.52M | 11.18M | 23.30M | -198.62M | 44.35M | 36.03M | 34.45M | 80.08M | 75.65M | 14.19M | -10.75M | 95.47M | 88.81M | 75.79M | 100.35M | 111.37M | 70.34M | 112.03M | 141.77M | 129.77M | |||||||||||||||||
| EBIT | 28.52M | 11.18M | 23.30M | -198.62M | 44.35M | 36.03M | 34.45M | 80.08M | 75.65M | 14.19M | -10.75M | 95.47M | 88.81M | 75.79M | 100.35M | 111.37M | 70.34M | 112.03M | 141.77M | 129.77M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -34.40M | -33.96M | -33.34M | -35.62M | -42.39M | -47.03M | -49.31M | -50.86M | -50.91M | -59.55M | -65.70M | -65.72M | -65.51M | -61.66M | -56.94M | -65.10M | -62.81M | -56.24M | -53.36M | -55.04M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 3.87M | 6.63M | 2.12M | 6.94M | 5.71M | 3.69M | 4.37M | 0.42M | -2.94M | -47.42M | 4.07M | 4.36M | 2.27M | 2.17M | 4.25M | 8.26M | -31.40M | -0.04M | -7.80M | -1.95M | |||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -30.56M | -27.49M | -33.23M | -34.11M | -42.17M | -43.69M | -43.88M | -50.42M | -52.69M | -97.65M | -64.78M | -75.06M | -73.39M | -91.11M | -62.86M | -59.66M | -75.57M | -56.80M | -61.60M | -58.78M | |||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | -2.04M | -16.32M | -9.92M | -232.73M | 2.18M | -7.66M | -9.43M | 29.66M | 22.96M | -83.46M | -75.52M | 20.41M | 15.42M | -15.32M | 37.49M | 51.71M | -5.22M | 55.23M | 80.18M | 70.99M | |||||||||||||||||
| Tax ProvisionsTaxes | 4.05M | 4.10M | -3.50M | 7.40M | 4.60M | -1.80M | 0.70M | -0.02M | -2.10M | 9.88M | 6.16M | 3.62M | 3.67M | 5.42M | 12.87M | 16.10M | -23.36M | 5.66M | 2.18M | 1.38M | |||||||||||||||||
| Profit After TaxPAT | -7.78M | -20.46M | -8.82M | -242.13M | -7.61M | 3.77M | -10.09M | 29.68M | 25.03M | -128.62M | -91.64M | 16.79M | 11.76M | -31.08M | 24.62M | 35.61M | 18.13M | 49.57M | 78.00M | 69.61M | |||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -1.85M | -14.08M | -4.74M | -119.27M | 0.30M | -1.52M | -3.15M | 17.77M | 15.35M | 5.30M | 9.96M | 10.79M | 11.91M | 10.34M | 12.42M | 13.19M | 15.76M | 14.50M | 15.74M | 11.95M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -6.09M | -20.42M | -6.42M | -240.13M | -2.42M | -5.86M | -10.13M | 29.68M | 25.06M | -93.34M | -81.68M | 16.79M | 11.76M | -20.74M | 24.62M | 35.61M | 18.13M | 49.57M | 78.00M | 69.61M | |||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -6.09M | -20.42M | -6.42M | -240.13M | -2.42M | -5.86M | -10.13M | 29.68M | 25.06M | -93.34M | -81.68M | 16.79M | 11.76M | -20.74M | 24.62M | 35.61M | 18.13M | 49.57M | 78.00M | 69.61M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -4.24M | -6.38M | -1.72M | -120.81M | -2.69M | -4.33M | -6.94M | 11.92M | 9.68M | -98.65M | -81.68M | 16.79M | 11.76M | -20.74M | 24.62M | 35.61M | 18.13M | 49.57M | 78.00M | 69.61M | |||||||||||||||||
| Preferred Dividend PaymentsPref Dividends | 0.44M | ||||||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -4.24M | -6.38M | -2.16M | -120.81M | -2.69M | -4.33M | -6.94M | 11.92M | 9.68M | -98.65M | -81.68M | 16.79M | 11.76M | -20.74M | 24.62M | 35.61M | 18.13M | 49.57M | 78.00M | 69.61M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.03 | -0.04 | -0.01 | -0.80 | -0.02 | -0.03 | -0.05 | 0.08 | 0.06 | -0.56 | -0.27 | 0.05 | 0.04 | -0.07 | 0.08 | 0.11 | 0.06 | 0.16 | 0.25 | 0.22 | |||||||||||||||||
| EPS (Diluted) | -0.03 | -0.04 | -0.01 | -0.80 | -0.02 | -0.03 | -0.05 | 0.08 | 0.06 | -0.56 | -0.27 | 0.05 | 0.04 | -0.07 | 0.08 | 0.11 | 0.06 | 0.15 | 0.24 | 0.21 | |||||||||||||||||
| Shares Outstanding | 149.29M | 148.92M | 149.89M | 150.99M | 151.39M | 150.94M | 152.11M | 153.74M | 154.22M | 176.14M | 307.28M | 309.12M | 309.65M | 308.98M | 311.05M | 313.74M | 314.17M | 313.37M | 316.02M | 319.20M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 149.29M | 151.82M | 149.89M | 150.99M | 151.39M | 150.94M | 152.11M | 154.89M | 159.69M | 176.14M | 307.28M | 318.96M | 309.65M | 308.98M | 323.96M | 322.36M | 324.75M | 324.81M | 328.93M | 328.10M | |||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 301.49M | 301.53M | 302.89M | 303.53M | 303.54M | 303.61M | 305.45M | 306.17M | 306.46M | 306.46M | 308.65M | 309.54M | 309.84M | 309.97M | 313.42M | 314.08M | 314.36M | 314.63M | 319.02M | 319.35M | |||||||||||||||||
| EBITDA | 28.52M | 11.18M | 23.30M | -198.62M | 44.35M | 36.03M | 34.45M | 80.08M | 75.65M | 14.19M | -10.75M | 95.47M | 88.81M | 75.79M | 100.35M | 111.37M | 70.34M | 112.03M | 141.77M | 129.77M | |||||||||||||||||
| Tax Rate | -198.19% | -25.12% | 35.28% | -3.18% | 211.01% | 23.51% | -7.43% | -0.08% | -9.15% | -11.84% | -8.15% | 17.73% | 23.77% | -35.40% | 34.33% | 31.14% | 447.16% | 10.25% | 2.71% | 1.94% |